Processa Pharmaceuticals Inc. (PCSA)
PCSA trades on Nasdaq in Health Care, Biotechnology: Pharmaceutical Preparations. Numbers below come from the Nasdaq screener and SEC filings, each with its source.
Price · October 14, 2026
$1.77
-6.84% on the day
Market cap
$5.0M
Nano cap
Revenue
No annual revenue filed since the period ending 2022-12-31
Net income
No annual revenue filed since the period ending 2022-12-31
Price, change, market cap, sector and industry: Nasdaq stock screener, as of October 14, 2026.
Profile
| Field | Value |
|---|---|
| Ticker | PCSA on Nasdaq |
| Sector | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations |
| Country | United States |
| IPO year | Not reported by the screener |
| SEC CIK | 0001533743 |
| SEC industry code | Pharmaceutical Preparations |
| Incorporated in | DE |
Financials
No annual revenue filed since the period ending 2022-12-31.
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest prospectus or offering document | S-3 | 2026-10-09 |
| Latest annual report | 10-K/A | 2026-04-30 |
| Latest quarterly / interim | 10-Q | 2026-08-14 |
| Latest current report | 8-K/A | 2026-10-05 |
| Latest proxy | PRE 14A | 2026-10-09 |
Source: SEC EDGAR submissions feed, 698 recent filings. All filings on EDGAR.
Peers in Biotechnology: Pharmaceutical Preparations
| Ticker | Company | Price | Day | Market cap |
|---|---|---|---|---|
| XBIO | Xenetic Biosciences Inc. | $2.10 | -0.94% | $4.9M |
| KALA | KALA BIO Inc. | $0.2600 | -7.14% | $5.0M |
| PULM | Pulmatrix Inc. | $1.38 | -3.50% | $5.0M |
| XTLB | XTL Biopharmaceuticals Ltd. | $1.98 | +3.12% | $4.9M |
| ADXN | Addex Therapeutics Ltd | $3.01 | -0.99% | $5.1M |
| GELS | Gelteq Limited | $0.4801 | -2.06% | $5.1M |
| LNAI | Lunai Bioworks Inc. | $1.03 | -7.21% | $4.7M |
| SCNX | Scienture Holdings Inc. | $3.24 | -17.14% | $5.3M |
The full dossier has every filing, three years of financials, private raises and the people who signed them.
Open the full dossier